Why has the uptake of lopinavir/ritonavir oral pellets for children been slow?
US regulators approve new two-drug combination pill for HIV
Non-adherence to HIV treatment for cost-saving reasons reported by 8% in American study
NHS England seeks drug price cuts to eliminate hepatitis C by 2025
No evidence of reduced efficacy or increased side-effects when patients switch to generic drugs, comparison study finds
Countries and donors should aim for new $90-$90-$90 target on HIV, hepatitis, TB drug prices, study shows
